ONE statement on vaccine IP waiver

WASHINGTON — The ONE Campaign released the following statement on the news that the United States will support waiving intellectual property protections for COVID-19 vaccines.

Tom Hart, Acting President and CEO of The ONE Campaign said:

“We need governments and industry to use every tool in their toolbox to dismantle the barriers that delay truly global access to COVID-19 vaccines, tests, and medicines. The TRIPS waiver is one such tool and today’s announcement by the Biden administration is welcome news.  A temporary waiver could create the right conditions to increase supply to COVID-19 countermeasures in the medium-term, alongside voluntary licensing and technology transfers. As TRIPS negotiations continue, urgent action is still needed to meet the immediate need for vaccines, diagnostics, and treatments around the world.

“We look forward to the Biden administration’s plan to share all 550 million surplus doses in 2021, and implement it as soon as possible. We also hope the ongoing negotiations kick off a broader discussion and agreement on new rules enabling the world to swiftly produce and deploy vaccines and therapeutics in declared pandemics and epidemics.”

 

Join the fight against extreme poverty

By signing you agree to ONE’s privacy policy, including to the transfer of your information to ONE’s servers in the United States.

Do you want to stay informed about how you can help fight against extreme poverty?

Sign up to receive emails from ONE and join millions of people around the world taking action to end extreme poverty and preventable disease. We’ll only ever ask for your voice, not your money. You can unsubscribe at any time.
Privacy options
Are you sure? If you select 'Yes' we can let you know how you can make a difference. You can unsubscribe at any time.

By signing you agree to ONE's privacy policy, including to the transfer of your information to ONE.org's servers in the United States.

You agree to receive occasional updates about ONE’s campaigns. You can unsubscribe at any time.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply